Mast cell activation disease: A concise practical guide for diagnostic workup and therapeutic options

被引:11
|
作者
Molderings, G. J. [1 ]
Homann, J. [2 ]
Brettner, S. [3 ]
Raithel, M. [4 ]
Frieling, T. [5 ]
机构
[1] Univ Klinikum Bonn, Inst Humangenet, D-53125 Bonn, Germany
[2] Gemeinschaftskrankenhaus Bonn, Innere Med Abt, Bonn, Germany
[3] Kreiskrankenhaus Waldbrol, Klin Onkol Hamatol & Palliat Med, Waldbrol, Germany
[4] Univ Klinikum Erlangen, Med Klin 1, Erlangen, Germany
[5] HELIOS Klinikum Krefeld, Med Klin 2, Krefeld, Germany
关键词
mast cell activation disease; systemic mastocytosis; mast cell activation syndrome; irtritable bowel; fibromyalgia; IRRITABLE-BOWEL-SYNDROME; KIT D816V MUTATION; SYSTEMIC MASTOCYTOSIS; CLINICAL-MANIFESTATIONS; TYROSINE KINASE; FIBROMYALGIA; PATHOGENESIS; AUTOCRINE; PREGNANCY; HYPERSENSITIVITY;
D O I
10.1055/s-0034-1370055
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In the present paper clinical phenotypes, pathogenetic relationships, and diagnostic algorithms as well as therapeutic concepts of/for systemic mast cell activation disease are reviewed. The reader should be able to recognize and diagnose a systemic mast cell activation disease, as well as to counsel a personalized drug therapy. In the case of chronic multisystem polymorbidity systemic mast cell activation disease should be considered as a differential diagnosis at an early stage. In most cases, specific, little invasive investigations allow diagnosing the disease and, hence, an appropriate therapy can be initiated. © Georg Thieme Verlag KG Stuttgart New York.
引用
收藏
页码:1523 / 1538
页数:16
相关论文
共 40 条
  • [21] Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome
    Valent, Peter
    Akin, Cem
    Bonadonna, Patrizia
    Hartmann, Karin
    Brockow, Knut
    Niedoszytko, Marek
    Nedoszytko, Boguslaw
    Siebenhaar, Frank
    Sperr, Wolfgang R.
    Elberink, Joanna N. G. Oude
    Butterfield, Joseph H.
    Alvarez-Twose, Ivan
    Sotlar, Karl
    Reiter, Andreas
    Kluin-Nelemans, Hanneke C.
    Hermine, Olivier
    Gotlib, Jason
    Broesby-Olsen, Sigurd
    Orfao, Alberto
    Horny, Hans-Peter
    Triggiani, Massimo
    Arock, Michel
    Schwartz, Lawrence B.
    Metcalfe, Dean D.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2019, 7 (04) : 1125 - +
  • [22] Mast Cell Activation Syndrome as a Significant Comorbidity in Sickle Cell Disease
    Afrin, Lawrence B.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2014, 348 (06) : 460 - 464
  • [23] Gastrointestinal manifestations of systemic mast cell activation disease - A practice-oriented guide to clinical picture, diagnostics and therapy
    Raithel, Martin
    Homann, Juergen
    Rieker, Ralf J.
    Molderings, Gerhard J.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2025, 63 (02): : 155 - 168
  • [24] Clinical and Laboratory Parameters of Mast Cell Activation as Basis for the Formulation of Diagnostic Criteria
    Valent, Peter
    Horny, Hans-Peter
    Triggiani, Massimo
    Arock, Michel
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2011, 156 (02) : 119 - 127
  • [25] Clinical Approach to Mast Cell Activation Syndrome: A Practical Overview
    Matito, A.
    Escribese, M. M.
    Longo, N.
    Mayorga, C.
    Luengo-Sanchez, O.
    Perez-Gordo, M.
    Matheu, V
    Labrador-Horrillo, M.
    Pascal, M.
    Seoane-Reula, M. E.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2021, 31 (06) : 461 - 470
  • [26] Hydroxychloroquine as a novel therapeutic approach in mast cell activation diseases
    Espinosa, Eric
    Valitutti, Salvatore
    Laroche, Michel
    Laurent, Camille
    Apoil, Pol Andre
    Hermine, Olivier
    Lavit, Michel
    Paul, Carle
    Livideanu, Cristina Bulai
    CLINICAL IMMUNOLOGY, 2018, 194 : 75 - 79
  • [27] Post-HPV-Vaccination Mast Cell Activation Syndrome: Possible Vaccine-Triggered Escalation of Undiagnosed Pre-Existing Mast Cell Disease?
    Afrin, Lawrence B.
    Dempsey, Tania T.
    Weinstock, Leonard B.
    VACCINES, 2022, 10 (01)
  • [28] Evidence for contribution of epigenetic mechanisms in the pathogenesis of systemic mast cell activation disease
    Britta Haenisch
    Holger Fröhlich
    Stefan Herms
    Gerhard J. Molderings
    Immunogenetics, 2014, 66 : 287 - 297
  • [29] Mast cell activation disease and the modern epidemic of chronic inflammatory disease
    Afrin, Lawrence B.
    TRANSLATIONAL RESEARCH, 2016, 174 : 33 - 59
  • [30] Omalizumab Treatment of Systemic Mast Cell Activation Disease: Experiences from Four Cases
    Molderings, Gerhard J.
    Raithel, Martin
    Kratz, Felix
    Azemar, Marc
    Haenisch, Britta
    Harzer, Sabrina
    Homann, Juergen
    INTERNAL MEDICINE, 2011, 50 (06) : 611 - 615